10x Genomics/ US88025U1097 /
5/31/2024 9:59:58 PM | Chg. +0.05 | Volume | Bid- | Ask- | High | Low |
---|---|---|---|---|---|---|
22.44USD | +0.22% | 47,936 Turnover: 1.07 mill. |
-Bid Size: - | -Ask Size: - | 22.87 | 22.07 |
GlobeNewswire
3/14
Johnson Fistel Announces Investigation of 10x Genomics (TXG) for Potential Securities Law Violations
GlobeNewswire
1/30
Johnson Fistel Announces Investigation of 10x Genomics (TXG) for Potential Securities Law Violations
GlobeNewswire
3/28/2022
Fluidigm Highlights the Strategic Capital Infusion by Casdin Capital and Viking Global as the Only A...
GlobeNewswire
8/31/2021
10x Genomics to Present at the Morgan Stanley 19th Annual Global Healthcare Conference
GlobeNewswire
8/6/2021
10x Genomics to Present at the UBS Genomics 2.0 and MedTech Innovations Summit
GlobeNewswire
6/10/2021
10x Genomics Unlocks Whole Transcriptome Analysis in FFPE Tissues With New Visium Assay, Now Shippin...
GlobeNewswire
4/29/2021
10x Genomics to Present at the BofA Securities 2021 Virtual Healthcare Conference
GlobeNewswire
4/1/2021
10x Genomics Puts Single Cell Analysis Within Reach of All With Low Throughput Gene Expression Kit
GlobeNewswire
3/9/2021
10x Genomics Expands Pleasanton Headquarters with New Facilities at Two Locations
GlobeNewswire
2/24/2021
10x Genomics Showcases Next Wave of Innovations at First Ever Xperience Event
GlobeNewswire
2/23/2021
Psomagen, Inc. Expands Precision Genomics Capabilities with 10x Genomics’ Single Cell Sequencing Tec...
GlobeNewswire
2/17/2021
10x Genomics Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Outlook for 20...
GlobeNewswire
1/28/2021
10x Genomics to Report Fourth Quarter and Full Year 2020 Financial Results on February 17, 2021